Hypertension and traditional risk factors for cardiovascular diseases among treatment naïve HIV- infected adults initiating antiretroviral therapy in Urban Tanzania
- PMID: 37340390
- PMCID: PMC10283332
- DOI: 10.1186/s12872-023-03332-6
Hypertension and traditional risk factors for cardiovascular diseases among treatment naïve HIV- infected adults initiating antiretroviral therapy in Urban Tanzania
Abstract
Background: Cardiovascular diseases (CVDs) have become an important cause of ill health and death among people living with HIV and/or AIDS (PLHIV) in the antiretroviral therapy (ART) era. There is scarce data on the burden of hypertension (HTN) and risk factors for CVDs among PLHIV in developing countries, including Tanzania during the ART era.
Objective(s): To determine the prevalence of HTN and risk factors for CVDs among ART naïve PLHIV initiating ART.
Methods: We analysed baseline data of 430 clinical trial participants on the effect of low-dose aspirin on HIV disease progression among HIV-infected individuals initiating ART. HTN was the outcome CVD. Traditional risk factors for CVDs studied were age, alcohol consumption, cigarette smoking, individual and family history of CVDs, diabetes mellitus (DM), obesity/overweight, and dyslipidaemia. A generalized linear model (robust Poisson regression) was used to determine the predictors for HTN.
Results: The median (IQR) age was 37 (28, 45) years. Females were the majority contributing 64.9% of all participants. The prevalence of HTN was 24.8%. The most prevalent risk factors for CVDs were dyslipidaemia (88.3%), alcohol consumption (49.3%), and overweight or obesity (29.1%). Being overweight or obese predicted the occurrence of HTN, aPR 1.60 (95% CI 1.16-2.21) while WHO HIV clinical stage 3 was protective against HTN, aPR 0.42(95% CI 0.18-0.97).
Conclusion: The prevalence of HTN and traditional risk factors for CVDs in the treatment naïve PLHIV initiating ART are significant. Identifying these risk factors and managing them at the time of ART initiation may lower future CVDs among PLHIV.
Keywords: Antiretroviral therapy; Cardiovascular diseases; Diabetes mellitus; Dyslipidaemia; HIV; Hypertension; Obesity; Tanzania.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
References
-
- Reniers G, Slaymaker E, Nakiyingi-Miiro J, Nyamukapa C, Crampin AC, Herbst K, et al. Mortality trends in the era of antiretroviral therapy: evidence from the network for analysing longitudinal population based HIV/AIDS data on Africa (ALPHA) Aids. 2014;28(September):533–42. doi: 10.1097/QAD.0000000000000496. - DOI - PMC - PubMed
-
- Joint United Nations Programme on HIV/ AIDS. IN DANGER: UNAIDS Global AIDS Update 2022. Geneva; 2022.
-
- Low A, Gavriilidis G, Larke N, B-Lajoie MR, Drouin O, Stover J, et al. Incidence of opportunistic infections and the impact of antiretroviral therapy among HIV-Infected adults in low- and Middle-Income Countries: a systematic review and Meta-analysis. Clin Infect Dis. 2016;62(12):1595–603. doi: 10.1093/cid/ciw125. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous